Errico Thomas J. purchased $49K of ECOR

Errico Thomas J. purchased 5,000 shares of electroCore, Inc. (ECOR) at $9.85 on 2026-08-13.

Original reporting
SEC EDGAR · Errico Thomas J.
Published Aug 17, 2026, 10:19 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 10:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ECOR
Bullish
medium confidence
Mentioned
$ECOR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ECORBullishLow
01

Why it matters

The only new information is the director’s open-market purchase details (shares, price, total value, and post-transaction holdings).

02

Market read

Traders may note the insider buy as a mild positive sentiment datapoint, but there is no accompanying fundamental update.

03

What to watch

The filing states no pre-arranged 10b5-1 plan, but it also provides no rationale for the purchase, and the dollar amount is relatively small.

Relevance 4/10Novelty 3/10Timing: filed today on SEC EDGAR, transaction dated 2026-08-13

Background

This is an SEC Form 4 insider transaction disclosure for electroCore, Inc. (ECOR).

Company-level read

Ticker impact

$ECORBullishMedium confidence
Context

electroCore director Errico Thomas J. bought 5,000 shares of ECOR in an open-market transaction for about $49.3K, filed as a Form 4.

Expected impact

Likely limited near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

Form 4 insider purchases can support bullish sentiment, but the disclosed size ($49K) is small relative to typical market-moving thresholds and contains no operational or financial updates.

Market effects

No clear sector read-through; this is a single-company insider transaction without new product or regulatory information.

None.

None.

Counterpoint

Insider buys can be routine (tax planning, diversification, or pre-existing intent) and may not reflect a change in business outlook.

Key entities

  • electroCore, Inc.

    Company whose director insider purchase was disclosed on Form 4.

  • Errico Thomas J.

    Director who purchased 5,000 shares of ECOR at $9.8544/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ECORMed

electroCore, Inc. (ECOR): Third quarter 2026 net sales of $9.7 million, an increase of 12% over $8.7 million in the third quarter of 2025

electroCore, Inc. (ECOR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 electroCore Announces Third Quarter 2026 Financial Results Third quarter 2026 net sales of $9.7 million, an increase of 12% over $8.7 million in the third quarter of 2025 Net loss of $1.3 million decreased 61% from prior year with Adjusted EBITDA net loss improving 6

$ECORMed

electroCore submits FDA 510(k) application for CIPN device

electroCore (NASDAQ:ECOR) submitted a 510(k) application to the FDA for its Quell device to treat chemotherapy-induced peripheral neuropathy (CIPN). The submission is based on two studies showing pain score reductions and improvements in neuropathy symptoms. FDA clearance is not guaranteed, and Quell is not currently approved for CIPN.

$ECORMed

electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)

electroCore, Inc. (ECOR) submitted a 510(k) premarket notification to the FDA seeking clearance for its Quell® device to treat chronic chemotherapy-induced peripheral neuropathy (CIPN). The submission is supported by clinical studies showing symptom improvements. If cleared, Quell would be among the first FDA-cleared devices for CIPN. The FDA review process is underway, with no guarantee of clearance.

$ECORMed

electroCore, Inc. (ECOR): Second quarter 2026 net sales of $9.5 million, an increase of 28% over $7.4 million in the second quarter 2025

electroCore, Inc. (ECOR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 electroCore Announces Second Quarter 2026 Financial Results Second quarter 2026 net sales of $9.5 million, an increase of 28% over $7.4 million in the second quarter 2025 Net loss of $3.1 million decreased 17% from prior year with Adjusted EBITDA net loss improving 2